08 | 06 | 2024

Nothing Left to Interpretation: How AI Prevented a Safety Filing Disaster

Every Word Counted: Inside the AI System That Turned 7,500 Pages Into a Submission Regulators Trusted | Case Study

There was no room for error. A global pharmaceutical company was preparing a critical set of safety documentation for submission to regulators in three regions. The pressure was high—any inconsistency between clinical summaries, technical documentation, and safety reporting could delay product approval, or worse, trigger compliance investigations.

Unlike previous cycles burdened by human cross-checking and siloed workflows, this time they used aiMDC. The AI read thousands of pages across multiple formats—clinical reports, safety data sheets, internal reviews—and returned insights that were not just fast, but verifiable. Every statement, every risk factor flagged, came with a link back to its original source — highlighted and timestamped.

With regulatory deadlines looming, the team used aiMDC’s “Show Highlights” feature to prepare bulletproof summaries and traceable assessments. Unlike generic AI tools that hallucinate or paraphrase inaccurately, aiMDC anchored every output to document reality. That made the difference between a last-minute scramble and confident, clean submission.

Client

A multinational pharmaceutical company preparing for EMA and FDA safety submissions for a new therapeutic line

Environment

High-stakes regulatory review involving multiple safety documents, requiring absolute accuracy and document traceability

Objective

To ensure zero-error, source-verified safety documentation for multi-region regulatory compliance, avoiding submission delays or audit risk

What was done

aiMDC was deployed to analyse 7,500+ pages across safety documents, clinical trial appendices, and compliance logs. The “Show Highlights” feature traced every AI-generated insight directly to the originating paragraph or section. Risk flags, inconsistencies, and summaries were surfaced, verified, and reviewed by the internal QA team within days, not weeks

Achievement

The pharma firm submitted a fully traceable, audit-ready safety package on schedule — avoiding what could have been a months-long delay and reputational damage. Regulators requested fewer clarifications than in prior submissions, attributing clarity and document traceability as key factors. By eliminating hallucinated or unsupported summaries, aiMDC helped the team avoid regulatory penalties and rework that could have cost millions in lost launch time. Just as crucially, it built internal confidence around AI—a tool they now trust with their most sensitive documentation.

What happens next…
Take control of your document challenges today. Connect with our experts, see aiMDC in action, and discover how precision AI can transform your workflow—saving you time, reducing risks, and boosting results. Ready to lead with confidence? Get started with aiMDC

OTHER CASE STUDIES

02 | 07 | 2025

The 500-Document Challenge: Winning Speed and Accuracy in Pharma Compliance

By using aiMDC, this biopharma company uncovered hidden compliance risks across hundreds of complex documents, fast-tracking their drug approval process and avoiding costly regulatory delays.
26 | 06 | 2025

The Deal That Didn’t Break Them: How One Private Equity Firm Avoided a Multi-Million Dollar Mistake with aiMDC

A private equity firm avoided a $30M loss by using aiMDC to detect hidden financial and legal risks across complex CIMs—proving the power of AI in high-stakes deal review.
06 | 04 | 2025

Lost in Translation? How One Pharma Giant Averted Regulatory Delay with AI

Facing a tight regulatory deadline, a top pharma firm used aiMDC to translate and analyze complex trial data across languages—avoiding costly delays and reputational risk
04 | 02 | 2025

Racing the Clock: How AI Accelerated Due Diligence and Prevented a Costly Misstep

aiMDC enabled a Private Equity firm to complete due diligence on a multi-company deal in 3 days, surfacing hidden risks and preventing an $18M overvaluation